Loading viewer...
investor_presentation
Format: PDF investor_presentation
H1 FY23 investor presentation covering Exide Life Insurance's financial performance, including revenue growth of 21%, PAT of Rs 6.9 billion, and a market share of 16.1%. The deck details profitability metrics, customer retention with 88% 13th-month persistency, capital adequacy at 210% solvency ratio, and updates on the Exide Life transaction integration.
brochure
investor_presentation
30 Pages
CDW
Teva Pharmaceutical Industries Investor Presentation — November 2020
investor_presentationinvestor_presentation
36 Pages
Teva Pharmaceutical Industries